Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06806163

Machine-Learning Prediction and Reducing Overdoses With EHR Nudges

Led by University of Pittsburgh · Updated on 2026-03-20

1350

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Pittsburgh

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a clinician-targeted behavioral nudge intervention embedded in the Electronic Health Record (EHR) to help identify patients at higher risk for opioid overdose using a machine-learning based risk prediction model. This trial aims to improve opioid prescribing safety and reduce overdose risk by comparing usual care to enhanced care with flags and behavioral nudges for clinicians in primary care settings. The study includes three groups: one receiving usual care without changes, one with an elevated-risk flag displayed in the EHR during patient encounters, and one with the flag combined with best practice alerts or behavioral nudges triggered under specific conditions. These nudges encourage safer prescribing, such as prescribing naloxone or providing justification for high opioid doses or overlapping prescriptions. Participants are patients who have received an opioid prescription and visited a primary care practice in the last year. Researchers will assess prescribing practices at 4 and 6 months after enrollment, including measures like naloxone prescriptions, opioid dosage, and overlapping medications. The study will monitor emergency department or inpatient visits for overdose and overall visits to evaluate the intervention's impact on patient safety and prescribing behavior.

CONDITIONS

Brief Title

Machine-Learning Prediction and Reducing Overdoses With EHR Nudges

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Received an opioid prescription within the past year
  • Age 18 years or older at the time of the opioid prescription
  • At least one visit to an internal medicine or family care practice within the past year
Not Eligible

You will not qualify if you...

  • Diagnosis of malignant cancer within the past year
  • Enrollment in hospice care

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or telephone)

Outpatient Treatment

Duration - Up to 6 months following enrollment

Participants receive care at primary care practices where clinicians may see an elevated-risk flag for opioid overdose during in-person or telephone encounters. Some participants’ clinicians will also receive behavioral nudges to encourage safer prescribing practices.

Visits occur during routine primary care encounters as needed

Trial Site Locations

Total: 1 location

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Actively Recruiting

Loading map...

Research Team

L

Lead Research Program Coordinator, CP3

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Similar Trials

Comparison of Dexamethasone Versus Dexmedetomidine Added to ...

Pain, Postoperative

Actively Recruiting

1 location

A Bundled Intervention to End Opioid Overdose by Increasing ...

Opioid Use Disorder

Actively Recruiting

1 location

A Randomized Controlled Trial Examining Extended-Release Inj...

Opioid Use Disorder

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.

Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang...

https://pubmed.ncbi.nlm.nih.gov/30901048

Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study.

Wei-Hsuan Lo-Ciganic, James L Huang, Hao H Zhang...

https://pubmed.ncbi.nlm.nih.gov/32678860

Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach.

Wei-Hsuan Lo-Ciganic, Julie M Donohue, Eric G Hulsey...

https://pubmed.ncbi.nlm.nih.gov/33735222

Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study.

Wei-Hsuan Lo-Ciganic, Julie M Donohue, Qingnan Yang...

https://pubmed.ncbi.nlm.nih.gov/35623798

Changes in predicted opioid overdose risk over time in a state Medicaid program: a group-based trajectory modeling analysis.

Jingchuan Guo, Walid F Gellad, Qingnan Yang...

https://pubmed.ncbi.nlm.nih.gov/35315173

Development and validation of an overdose risk prediction tool using prescription drug monitoring program data.

Walid F Gellad, Qingnan Yang, Kayleigh M Adamson...

https://pubmed.ncbi.nlm.nih.gov/37001323

Design and development of a machine-learning-driven opioid overdose risk prediction tool integrated in electronic health records in primary care settings.

Khoa Nguyen, Debbie L Wilson, Julie Diiulio...

https://pubmed.ncbi.nlm.nih.gov/39420438

Machine Learning Prediction and Reducing Overdoses With Electronic Health Record Nudges (mPROVEN) in the Primary Care Setting: Protocol for a Cluster Randomized Controlled Trial.

Walid F Gellad, Yi-Fan Chen, Tae Woo Park...

https://pubmed.ncbi.nlm.nih.gov/42081274